Defense Tech Startup Valuation by Funding Stage: Q2 2026 Benchmarks
Defense Tech startup valuations do not increase predictably with funding stage.
Finro’s Q2 2026 analysis of 168 private Defense Tech companies shows a non-linear relationship between funding stage and EV/Revenue multiples. The median rises from 13.3x at Seed to 19.7x at Series A, falls to 12.7x at Series B, climbs to 35.5x at Series D, and then declines to 24.7x at Late Stage.
This matters because funding stage is often used as a shortcut when benchmarking private-company valuations. A Series C or Series D company may be more mature than a Series A company, but that does not automatically justify a higher revenue multiple.
Finro’s broader Q2 2026 Defense Tech valuation analysis shows that valuations also vary materially by niche, company type, and transaction context. This analysis focuses specifically on the funding-stage dimension: how valuation multiples differ from Seed through Late Stage, why the progression is not linear, and which company-specific factors matter when applying these benchmarks to a Defense Tech startup.
-
01Defense Tech valuation multiples do not increase linearly with funding stage. Median EV/Revenue multiples move from 13.3x at Seed to 19.7x at Series A, fall to 12.7x at Series B, and reach 35.5x at Series D before declining again at Late Stage.
-
02Series D carries the highest median multiple in Finro's Q2 2026 funding-stage analysis. Series D Defense Tech companies have a median EV/Revenue multiple of 35.5x, compared with 24.7x for Late Stage companies and 19.7x for Series A companies.
-
03Companies within the same funding stage can still carry very different valuations. The wide 25th-to-75th percentile ranges across most stages show that a funding-round label alone is not enough to establish a credible valuation benchmark.
-
04Business fundamentals and comparable companies matter more than stage alone. Defense Tech niche, revenue growth, contract visibility, customer concentration, revenue model, margins, technology, scalability, and capital requirements can materially affect the appropriate valuation multiple.
Topics covered in this analysis +
- Defense Tech Startup Valuation by Funding Stage
- Why Defense Tech Multiples Do Not Rise With Funding Stage
- Seed and Series A Defense Tech Valuations
- Series B and Series C Defense Tech Valuations
- Series D and Late-Stage Defense Tech Valuations
- What Matters More Than Funding Stage?
- How to Use Funding-Stage Benchmarks
- Defense Tech Dataset and Methodology
- Defense Tech Funding Stage Valuation FAQs
Defense Tech Startup Valuation by Funding Stage
Finro’s Q2 2026 funding-stage analysis covers 168 private Defense Tech companies from Seed through Late Stage. The data shows substantial differences in EV/Revenue multiples across funding stages, but not a steady increase as companies move through successive rounds.
Series D companies record the highest median EV/Revenue multiple at 35.5x, followed by Late Stage companies at 24.7x and Series A companies at 19.7x. Series C sits at 16.6x, while Seed and Series B companies have the lowest medians at 13.3x and 12.7x, respectively.
The percentile ranges show that funding stage provides only part of the valuation picture. Series A companies, for example, have a median multiple of 19.7x, but the middle 50% of observations range from 9.6x to 36.2x. For Series D, the equivalent range is even wider, from 19.6x to 56.9x.
There is also a significant gap between median and average multiples across most stages. The difference is particularly pronounced at Series C, where the median is 16.6x but the average reaches 84.2x. This indicates that a relatively small number of high-multiple observations can materially distort the average, making the median and percentile range more useful reference points when comparing Defense Tech startups.
For valuation purposes, the stage benchmarks are therefore better treated as a range of market observations than as a fixed multiple for a Seed, Series A, or later-stage Defense Tech company.
Defense Tech Valuation Multiples by Funding Stage
EV/Revenue benchmarks for 168 private Defense Tech companies, segmented from Seed through Late Stage.
| Funding Stage | Companies | Median EV/Revenue | Average EV/Revenue | 25th–75th Percentile |
|---|---|---|---|---|
| Seed | 19 | 13.3x | 26.3x | 7.6x–31.5x |
| Series A | 40 | 19.7x | 41.7x | 9.6x–36.2x |
| Series B | 44 | 12.7x | 33.6x | 7.9x–32.6x |
| Series C | 19 | 16.6x | 84.2x | 11.4x–26.2x |
| Series D | 18 | 35.5x | 51.1x | 19.6x–56.9x |
| Late Stage | 28 | 24.7x | 51.9x | 11.9x–41.0x |
Defense Tech revenue multiples do not increase consistently with funding stage. Series A companies carry a higher median multiple than Series B and Series C companies, while Series D records the highest median before the benchmark falls again at Late Stage.
Why Defense Tech Multiples Do Not Rise With Funding Stage
If funding stage were a reliable proxy for valuation, Defense Tech revenue multiples would be expected to increase as companies move from Seed through later rounds. Finro’s Q2 2026 data shows a different pattern.
The median EV/Revenue multiple rises from 13.3x at Seed to 19.7x at Series A, but then falls to 12.7x at Series B. It recovers to 16.6x at Series C and jumps to 35.5x at Series D, before falling again to 24.7x at Late Stage.
This does not mean that a typical Series B company is less valuable than a Series A company. EV/Revenue measures how enterprise value compares with revenue, not absolute company valuation. A later-stage company can have substantially higher revenue and enterprise value while trading at a lower revenue multiple.
The pattern also reflects how the companies within each funding stage differ. Defense Tech startups do not mature along a uniform path. A capital-intensive hardware company, a defense software platform with recurring revenue, and a deep-tech components business may reach the same funding stage with very different revenue profiles, margins, contract structures, capital requirements, and growth expectations.
Funding stage therefore describes where a company sits in its financing history, but only partially explains how investors price its revenue. As companies mature, actual financial performance, revenue visibility, contract quality, market position, and the economics of the underlying business increasingly influence the valuation multiple.
The wide percentile ranges within each stage reinforce this point. Series A companies in the dataset span 9.6x to 36.2x between the 25th and 75th percentiles, while Series D spans 19.6x to 56.9x. Companies at the same funding stage can therefore occupy very different parts of the valuation range.
Funding Stage Is Not a Valuation Multiple
A Series B company can be worth substantially more than a Series A company while trading at a lower EV/Revenue multiple. Funding stage reflects a company's financing history, while the valuation multiple reflects how the market prices its revenue, growth, risk, and expected financial performance. The two should not be treated as interchangeable valuation benchmarks.
Seed and Series A Defense Tech Valuations
Seed-stage Defense Tech companies in Finro’s Q2 2026 dataset have a median EV/Revenue multiple of 13.3x, based on 19 companies. The middle 50% of observations range from 7.6x to 31.5x, showing considerable valuation dispersion even at the earliest funding stage included in the analysis.
At Series A, the median increases to 19.7x across 40 companies, with a 25th-to-75th percentile range of 9.6x to 36.2x. The 48% increase in the median from Seed to Series A is one of the clearer upward movements between consecutive funding stages in the dataset.
There are several reasons why companies reaching Series A may command stronger revenue multiples. By this stage, investors may have more evidence around product-market fit, customer adoption, contract execution, and the commercial viability of the underlying technology. Some companies will also have moved beyond initial development into repeatable revenue generation, reducing part of the execution risk present at Seed.
Defense Tech introduces additional considerations. Early customer contracts, government procurement progress, successful technical validation, proprietary IP, and evidence that a product can move from prototype to deployment can materially change the risk profile between financing rounds.
However, the wide ranges at both stages are important. A Seed company near the upper quartile can carry a substantially higher revenue multiple than many Series A companies. Funding progression therefore provides useful context, but the underlying commercial and technology milestones achieved between rounds are more relevant to valuation than the Series A label itself.
19 companies · 25th–75th percentile: 7.6x–31.5x
40 companies · 25th–75th percentile: 9.6x–36.2x
Series B and Series C Defense Tech Valuations
Series B is where the funding-stage pattern becomes less intuitive. The median EV/Revenue multiple falls to 12.7x across 44 companies, down from 19.7x at Series A. The middle 50% of Series B observations range from 7.9x to 32.6x.
At Series C, the median recovers to 16.6x across 19 companies, with a considerably tighter 25th-to-75th percentile range of 11.4x to 26.2x. The median is therefore higher than at Series B, but still below the Series A benchmark.
This is a useful reminder that later funding rounds do not automatically translate into higher revenue multiples. By Series B and Series C, investors typically have more operating data to evaluate. Revenue quality, growth rates, contract visibility, customer concentration, margins, and capital efficiency can become more influential than the simple fact that the company has raised another round.
The Series C data also highlights why averages can be misleading in Defense Tech valuation analysis. While the median multiple is 16.6x, the average reaches 84.2x. That gap suggests a small number of very high-multiple companies are pulling the average sharply upward.
For benchmarking purposes, the 16.6x median and 11.4x to 26.2x interquartile range provide a more representative reference point for Series C companies than the average alone.
44 companies · 25th–75th percentile: 7.9x–32.6x
19 companies · 25th–75th percentile: 11.4x–26.2x
Series D and Late-Stage Defense Tech Valuations
Series D represents the highest valuation point in Finro’s Q2 2026 funding-stage analysis. Across 18 Series D Defense Tech companies, the median EV/Revenue multiple reaches 35.5x, more than double the 16.6x median recorded at Series C.
The valuation range is also elevated. The middle 50% of Series D companies trade between 19.6x and 56.9x revenue, while the average multiple stands at 51.1x. This suggests that the higher Series D median is not driven solely by a small number of extreme observations.
The pattern changes again at Late Stage. Across 28 companies, the median EV/Revenue multiple falls to 24.7x, with the middle 50% ranging from 11.9x to 41.0x. Late Stage therefore carries the second-highest median in the analysis, but sits roughly 30% below Series D.
One possible explanation is that later-stage companies are increasingly valued against demonstrated financial performance rather than primarily against future potential. As revenue bases become larger and operating histories longer, investors have more evidence to assess growth, margins, contract concentration, capital requirements, and the path toward profitability. Higher absolute enterprise values do not necessarily require higher revenue multiples.
The Late Stage category is also broader than a single financing round. It includes companies beyond Series D, including Series E and later rounds, private equity-backed companies, late-stage growth businesses, and pre-IPO companies. These businesses can have materially different financial profiles and capital structures, which contributes to the range of multiples observed within the category.
18 companies · 25th–75th percentile: 19.6x–56.9x
28 companies · 25th–75th percentile: 11.9x–41.0x
What Matters More Than Funding Stage?
Funding stage provides a useful reference point for Defense Tech startup valuation, but it does not explain why two companies at the same stage can trade at very different revenue multiples.
Finro’s Q2 2026 data shows this clearly. The middle 50% of Series A companies range from 9.6x to 36.2x EV/Revenue, while Series D companies range from 19.6x to 56.9x. A funding-round label alone cannot explain that level of dispersion.
Several company-specific factors can have a greater influence on the appropriate valuation benchmark:
Defense Tech niche. Business models differ materially across defense software, autonomous systems, cybersecurity, space, components, and manufacturing. Finro’s broader Defense Tech valuation analysis shows median EV/Revenue multiples ranging from 4.4x to 20.8x across eight Defense Tech niches.
Revenue growth and visibility. Two Series B companies with similar current revenue can warrant different multiples if one has stronger contracted growth, backlog, recurring revenue, or greater visibility into future deployments.
Contract quality and customer concentration. Long procurement cycles and concentrated government or prime-contractor relationships are common in Defense Tech. The quality, duration, renewal characteristics, and concentration of those contracts can materially affect the risk attached to future revenue.
Technology and intellectual property. Proprietary technology, technical differentiation, certification, switching costs, and barriers to replication can support a stronger valuation, particularly where they translate into a defensible competitive position.
Margins and scalability. A software-led company with high incremental margins has a different financial profile from a capital-intensive manufacturer, even if both are classified as Defense Tech and have raised the same funding round.
Capital requirements. Companies requiring substantial manufacturing capacity, inventory, infrastructure, or continued R&D funding may need to be assessed differently from businesses capable of scaling revenue with comparatively limited additional capital.
The practical implication is that funding stage should narrow the comparable-company universe, not determine the valuation multiple. A Series B Defense Tech startup should first be compared with businesses that resemble its economics, market position, and operating model. Funding stage can then provide an additional layer of context.
Start with comparable companies. Then use funding stage to refine the benchmark, not the other way around.
A relevant peer group should reflect the company's niche, business model, revenue profile, growth, and operating economics before funding stage is used as an additional valuation filter. Explore Finro's valuation approachHow to Use Funding-Stage Benchmarks
Funding-stage multiples are most useful as a reference layer within a broader comparable-company analysis. They can help test whether a proposed valuation sits within the range observed for companies at a similar point in their financing cycle, but they should not be applied mechanically to revenue.
A practical approach is to start with the company’s operating profile and progressively narrow the peer group. For a Defense Tech startup, this means first identifying companies with similar products, customers, revenue models, margins, and capital requirements. The relevant Defense Tech niche should then be considered before filtering the comparison further by funding stage.
Once an appropriate peer group has been established, the funding-stage data can provide an additional reasonableness check. For example, the Q2 2026 Series B benchmark has a median EV/Revenue multiple of 12.7x and an interquartile range of 7.9x to 32.6x. A Series B company trading outside that range is not necessarily mispriced, but the difference should be supported by company-specific factors such as stronger growth, contract visibility, technology differentiation, or weaker operating economics.
The same principle applies when selecting a point within the benchmark range. Companies with stronger recurring revenue, defensible technology, high-quality contracts, scalable economics, and lower execution risk may justify positioning toward the upper end. Businesses with concentrated customers, uncertain deployment schedules, weaker margins, or significant future capital requirements may warrant a lower benchmark.
Finally, the implied multiple should be cross-checked against other valuation approaches where appropriate. Depending on the company’s maturity and available information, this can include broader comparable-company analysis, precedent M&A transactions, EV/Funding benchmarks, and a DCF based on credible financial projections.
The objective is therefore not to answer, “What multiple should a Series B Defense Tech company receive?” It is to determine whether the valuation implied by the company’s fundamentals is consistent with the range of outcomes observed for relevant Defense Tech peers.
A Better Way to Use Funding-Stage Benchmarks
Start with the product, revenue model, customers, margins, growth profile, and capital requirements.
Identify Defense Tech companies with similar economics, market positioning, and operating models.
Use Seed, Series A, Series B, or later-stage benchmarks to refine the comparison rather than define it.
Compare the implied valuation with other multiples, transactions, funding benchmarks, or DCF analysis.
Defense Tech Dataset and Methodology
Finro’s Q2 2026 Defense Tech funding-stage analysis covers 168 private Defense Tech companies from Seed through Late Stage. Companies are grouped from Seed through Late Stage to compare how private-market valuation multiples differ across the funding cycle.
The analysis uses EV/Revenue as the primary valuation metric. For each funding stage, Finro calculates the median, average, 25th percentile, and 75th percentile using companies with sufficient valuation and revenue data. Median multiples are used as the primary benchmark because high-multiple observations can materially increase stage-level averages.
Funding stages are based on the company’s latest identified financing stage. Seed, Series A, Series B, Series C, and Series D are analyzed separately. Late Stage combines Series E and later rounds with private equity-backed companies, late-stage growth financings, and pre-IPO rounds.
The 168-company funding-stage sample forms part of Finro’s broader Q2 2026 Defense Tech dataset, which covers 317 public companies, private companies, and M&A transactions across eight Defense Tech niches. The broader dataset provides additional context for comparing funding-stage benchmarks with niche, public-market, private-market, and transaction multiples. Finro’s full Defense Tech valuation analysis explains the wider methodology and market findings.
These benchmarks are intended to support comparable-company analysis rather than prescribe a valuation multiple for a particular funding stage. Individual company valuations can differ materially depending on growth, revenue quality, contracts, margins, technology, capital requirements, and the composition of the relevant peer group.
Go Beyond the Funding-Stage Benchmarks
Explore the company-level data behind Finro's Q2 2026 Defense Tech analysis, including public companies, private companies, M&A transactions, funding stages, valuation multiples, and financial data across eight Defense Tech niches.
- 1 Funding stage does not produce a linear progression in Defense Tech valuation multiples. Median EV/Revenue rises from 13.3x at Seed to 19.7x at Series A, falls to 12.7x at Series B, reaches 35.5x at Series D, and declines to 24.7x at Late Stage.
- 2 Series D has the highest median multiple in Finro's Q2 2026 funding-stage analysis. The Series D median reaches 35.5x, compared with 16.6x at Series C and 24.7x at Late Stage.
- 3 Companies at the same funding stage can still carry very different valuation multiples. The middle 50% of Series A observations range from 9.6x to 36.2x, while Series D ranges from 19.6x to 56.9x.
- 4 Median multiples are generally more useful than averages for stage benchmarking. Series C has a median EV/Revenue multiple of 16.6x but an average of 84.2x, showing how high-multiple outliers can materially distort the average.
- 5 Funding stage should refine the comparable-company analysis, not determine the valuation. Niche, growth, contract visibility, revenue quality, margins, technology, scalability, and capital requirements remain important when selecting an appropriate benchmark.
